Trial In Progress: Open-Label Dose-Finding and Dose-Expansion Study to Evaluate the Safety, Expansion, Persistence, and Clinical Activity of UCART20x22 in Subjects with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL) NatHali-01 – ASH 2025
Download the PDF file